Home Business

Natco Pharma FY09 net rises 8.5% at Rs 44 cr

Hyderabad-based drug maker Natco Pharma reported an 8.5 per cent rise in its consolidated net profit at Rs 43.98 crore for the year ended March 2009, compared with Rs 40.52 crore posted in the previous year. - Lupin buys worldwide rights for nasal spray AllerNaze - Glenmark"s diabetes drug to enter phase lll trials - Emami realty arm to be listed on BSE in 3-4 months - Piramal Healthcare gets nod for appt of Nandini Piramal as ED - Sun Pharma gets USFDA nod for anti hypertensive drug - Step up vigil to stop fake Made-in-India drugs in Africa: govt Revenues were up to Rs 465 crore from Rs 364 crore in the same period, registering a growth of 28 per cent. The company stated that the growth in profit was lower on account of expenses on Phase I clinical trials of its new chemical entity with multiple oncological indications.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Hiring activity up 4.1% in September: Naukri JobSpeak
Hiring activity is finally gathering steam among the Indian corporates. The job index increased by 4.1 per cent in Septmeber 2009 as compared to August 09, said the findings of Naukri JobSpeak. On the three month moving average, the index inched up from 715 in August ’09 to 719 in September’09.
Popular Articles

Look at the dark side
Partition in Bengal, despair in Delhi and power games in Tudor England: three new books to read.

First unit of Hissar power project becomes operational
The first 600 Mw unit of Rajiv Gandhi Thermal Power Project at Khedar in Hissar district, which will supply power to Haryana, was synchronised with the grid today by Chief Minister of Haryana Bhupinder Singh Hooda.

© Copyright 2009